Phase II study of adagrasib + stereotactic radiosurgery (SRS) for patients with metastatic KRAS G12C-mutated NSCLC with untreated brain metastases

Status: Open to Accrual

Learn more:

• https://clinicaltrials.gov/study/NCT06248606

Study Contact: studies@hoosiercancer.org; (317) 921-2050.